Back
Crinetics Pharmaceuticals Stock Price Chart
Write This Down: Tuesday at 2 p.m. ET!
Don't Miss Our LIVE Trade
Buy
76
CRNX
Crinetics Pharmaceuticals
Last Price:
60.68
Seasonality Move:
5.63%
7 Day Trial
ALL ACCESS PASS
$
7
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRNX is experiencing buying pressure, which is a positive indicator for future bullish movement.
Crinetics Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 57.83 | Buy |
| 20-day SMA: | 57.56 | Buy |
| 50-day SMA: | 54.18 | Buy |
| 200-day SMA: | 47.92 | Buy |
| 8-day EMA: | 58.58 | Buy |
| 20-day EMA: | 57.17 | Buy |
| 50-day EMA: | 54.96 | Buy |
| 200-day EMA: | 47.55 | Buy |
Crinetics Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.44 | Buy |
| Relative Strength Index (14 RSI): | 68.84 | Buy |
| Chaikin Money Flow: | 432172 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (53.49 - 59.33) | Buy |
| Bollinger Bands (100): | (48.24 - 56.26) | Buy |
Crinetics Pharmaceuticals Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Crinetics Pharmaceuticals Stock
Is Crinetics Pharmaceuticals Stock a Buy?
- Crinetics Pharmaceuticals share price is 60.69 while CRNX 8-day simple moving average is 57.83, which is a Buy signal.
- The stock price of CRNX is 60.69 while Crinetics Pharmaceuticals 20-day SMA is 57.56, which makes it a Buy.
- Crinetics Pharmaceuticals 50-day simple moving average is 54.18 while CRNX share price is 60.69, making it a Buy technically.
- CRNX stock price is 60.69 and Crinetics Pharmaceuticals 200-day simple moving average is 47.92, creating a Buy signal.
CRNX Technical Analysis vs Fundamental Analysis
Buy
76
Crinetics Pharmaceuticals (CRNX)
is a Buy
Is Crinetics Pharmaceuticals a Buy or a Sell?
-
Crinetics Pharmaceuticals stock is rated a Buy
The current Crinetics Pharmaceuticals [CRNX] share price is $60.69. The Score for CRNX is 76, which is 52% above its historic median score of 50, and infers lower risk than normal.
Crinetics Pharmaceuticals Stock Info
Market Cap:
4.86B
Price in USD:
60.69
Share Volume:
573.29K
Crinetics Pharmaceuticals 52-Week Range
52-Week High:
60.93
52-Week Low:
25.75
Buy
76
Crinetics Pharmaceuticals (CRNX)
is a Buy
Crinetics Pharmaceuticals Share Price Forecast
-
What is the Crinetics Pharmaceuticals stock price today?
The Crinetics Pharmaceuticals stock price is 60.69 USD today. -
Will CRNX stock go up or go down?
Crinetics Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Crinetics Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Crinetics Pharmaceuticals is not overvalued.
Is Crinetics Pharmaceuticals Stock a Buy?
- Crinetics Pharmaceuticals share price is 60.69 while CRNX 8-day exponential moving average is 58.58, which is a Buy signal.
- The stock price of CRNX is 60.69 while Crinetics Pharmaceuticals 20-day EMA is 57.17, which makes it a Buy.
- Crinetics Pharmaceuticals 50-day exponential moving average is 54.96 while CRNX share price is 60.69, making it a Buy technically.
- CRNX stock price is 60.69 and Crinetics Pharmaceuticals 200-day simple moving average is 47.55, creating a Buy signal.
Fundamental Analysis of Crinetics Pharmaceuticals
Is Crinetics Pharmaceuticals a good investment?
- Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.04 per share, and a decrease next year of $0.21 per share.
Technical Analysis of Crinetics Pharmaceuticals
Should I short Crinetics Pharmaceuticals stock?
- CRNX Moving Average Covergence Divergence (MACD) indicator is 1.44, suggesting Crinetics Pharmaceuticals is a Buy
- Crinetics Pharmaceuticals Relative Strength Index (RSI) is 68.84, which suggest Crinetics Pharmaceuticals is overbought
- The Bollinger Bands (25) for Crinetics Pharmaceuticals is (53.49 - 59.33), which suggest Crinetics Pharmaceuticals is a Buy
- The Bollinger Bands (100) for Crinetics Pharmaceuticals is (48.24 - 56.26), which suggest Crinetics Pharmaceuticals is a Buy
* Crinetics Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.